Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population

<div>Urine exosomal PCA3/PRAC predicts the biopsy outcome. For each cohort, ROC curve analysis is performed for (a) any-grade and (b) high-grade prostate cancer to determine the AUC for LBXexo, PCA3 alone, and PSA test, respectively. ROC, receiver-operating characteristic; AUC, area under the curve.</div>

Prostate Cancer

fig2

Figure 2

Figure 2: Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population 

Figure 2 | Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population 